The IMA Group (IMA) today announced it had completed the acquisition of Clinical Trials of America (CTA), a multi-therapeutic clinical trials company that brings to IMA four new independent and six embedded site locations in Louisiana and North Carolina. With CTA’s deep therapeutic expertise in cardiology, gastroenterology, dermatology, vaccines, family medicine and psychiatry, the transaction adds scale, enhances diversity and further extends the reach of IMA Clinical Research in the Southeast. The transaction marks the seventh acquisition the IMA Group’s Clinical Research division has completed since 2018 and the 15th total acquisition within the company in the same period.
Read the full article: The IMA Group Acquires Clinical Trials of America //
Source: https://www.businesswire.com/news/home/20230111005177/en/The-IMA-Group-Acquires-Clinical-Trials-of-America